5 research outputs found

    Death Toll From Uncontrolled Blood Pressure in Ethnic Populations: Universal Access and Quality Improvement May Not Be Enough

    Get PDF
    Cardiovascular disease (CVD) is the number 1 cause of death globally.1 An estimated 17.5 million people died from CVD in 2005 (7.6 million from coronary heart disease and 7.6 million from stroke), representing 30% of all global deaths.2 Globally, two-thirds of stroke and one-half of ischemic heart disease are attributable to nonoptimal blood pressure. Worldwide, nonoptimal blood pressure contributes to approximately 12.8% of all deaths (7.1 million) and 4.4% of all disability-adjusted life years (64.3 million) in the year 2000. These proportions are highest in more developed countries, such as the United States and the United Kingdom.3 Racial and ethnic disparities in cardiovascular disease prevalence, treatment, and outcomes are well documented in the United States, and racial and ethnic differences in hypertension are no exception.4-7 Cardiovascular disease accounts for 35% of excess overall mortality in US blacks, largely because of hypertension.8 In Europe, ethnic differences in hypertension prevalence and morbidity and mortality from cardiovascular disease have also been described

    Covid-19 and Health Equity — Time to Think Big

    No full text

    Taking action to advance the study of race and ethnicity: the Women's Health Initiative (WHI).

    No full text
    "Race" and "ethnicity" are socially constructed terms, not based on biology - in contrast to biologic ancestry and genetic admixture - and are flexible, contested, and unstable concepts, often driven by power. Although individuals may self-identify with a given race and ethnic group, as multidimensional beings exposed to differential life influencing factors that contribute to disease risk, additional social determinants of health (SDOH) should be explored to understand the relationship of race or ethnicity to health. Potential health effects of structural racism, defined as "the structures, policies, practices, and norms resulting in differential access to goods, services, and opportunities of society by "race," have been largely ignored in medical research. The Women's Health Initiative (WHI) was expected to enroll a racially and ethnically diverse cohort of older women at 40 U.S. clinical centers between 1993 and 1998; yet, key information on the racial and ethnic make-up of the WHI cohort of 161,808 women was limited until a 2020-2021 Task Force was charged by the WHI Steering Committee to better characterize the WHI cohort and develop recommendations for WHI investigators who want to include "race" and/or "ethnicity" in papers and presentations. As the lessons learned are of relevance to most cohorts, the essence of the WHI Race and Ethnicity Language and Data Interpretation Guide is presented in this paper. Recommendations from the WHI Race and Ethnicity Language and Data Interpretation Guide include: Studies should be designed to include all populations and researchers should actively, purposefully and with cultural-relevance, commit to recruiting a diverse sample; Researchers should collect robust data on race, ethnicity and SDOH variables that may intersect with participant identities, such as immigration status, country of origin, acculturation, current residence and neighborhood, religion; Authors should use appropriate terminology, based on a participant's self-identified "race" and "ethnicity", and provide clear rationale, including a conceptual framework, for including race and ethnicity in the analytic plan; Researchers should employ appropriate analytical methods, including mixed-methods, to study the relationship of these sociocultural variables to health; Authors should address how representative study participants are of the population to which results might apply, such as by age, race and ethnicity
    corecore